97 related articles for article (PubMed ID: 9282795)
1. Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus.
Sumida Y; Wada H; Fujii M; Mori Y; Nakasaki T; Shimura M; Hiyoyama K; Yano Y; Deguchi K; Shiku H; Adachi Y
Blood Coagul Fibrinolysis; 1997 Jul; 8(5):303-7. PubMed ID: 9282795
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
3. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
Fujiwara Y; Tagami S; Kawakami Y
J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombo-test monitoring.
Ikuma H; Wada H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Nishikawa M; Onoda K; Yamada N; Ohta T; Nishioka J; Nobori T; Gabazza EC; Sakuragawa N; Shiku H
Blood Coagul Fibrinolysis; 1999 Oct; 10(7):429-34. PubMed ID: 10695769
[TBL] [Abstract][Full Text] [Related]
5. Protein C activation in NIDDM patients.
Gabazza EC; Takeya H; Deguchi H; Sumida Y; Taguchi O; Murata K; Nakatani K; Yano Y; Mohri M; Sata M; Shima T; Nishioka J; Suzuki K
Diabetologia; 1996 Dec; 39(12):1455-61. PubMed ID: 8960826
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic abnormalities following bone marrow transplantation.
Tamaki S; Wada H; Ohfuzi K; Shibata T; Masuya M; Kageyama S; Gabazza EC; Kawakami K; Tsuji K; Miyanishi E; Minami N; Nobori T; Shiku H
Clin Appl Thromb Hemost; 2002 Apr; 8(2):125-32. PubMed ID: 12121052
[TBL] [Abstract][Full Text] [Related]
7. Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia.
Nakasaki T; Wada H; Mori Y; Okugawa Y; Watanabe R; Nishikawa M; Gabazza EC; Masuya M; Kageyama S; Kumeda K; Kato H; Shiku H
Am J Hematol; 2000 Jul; 64(3):145-50. PubMed ID: 10861807
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H
Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
Wada H; Sakuragawa N; Shiku H
Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
[TBL] [Abstract][Full Text] [Related]
10. Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients.
Hirano T; Kashiwazaki K; Moritomo Y; Nagano S; Adachi M
Diabetes Res Clin Pract; 1997 Apr; 36(1):11-8. PubMed ID: 9187410
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
Inoue A; Wada H; Takagi M; Yamamuro M; Mukai K; Nakasaki T; Shimura M; Hiyoyama K; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Shiku H
Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
[TBL] [Abstract][Full Text] [Related]
12. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes.
Aso Y; Fujiwara Y; Tayama K; Takebayashi K; Inukai T; Takemura Y
Clin Chim Acta; 2000 Nov; 301(1-2):135-45. PubMed ID: 11020468
[TBL] [Abstract][Full Text] [Related]
13. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria.
Yano Y; Kitagawa N; Gabazza EC; Morioka K; Urakawa H; Tanaka T; Katsuki A; Araki-Sasaki R; Hori Y; Nakatani K; Taguchi O; Sumida Y; Adachi Y
J Clin Endocrinol Metab; 2003 Feb; 88(2):736-41. PubMed ID: 12574207
[TBL] [Abstract][Full Text] [Related]
15. Effects of heparin treatment on hemostatic abnormalities in obese non-insulin-dependent diabetic patients.
Avellone G; di Garbo V; Cordova R; Rotolo G; Raneli G; de Simone R; Bompiani G
Metabolism; 1997 Aug; 46(8):930-4. PubMed ID: 9258277
[TBL] [Abstract][Full Text] [Related]
16. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury.
Aso Y; Inukai T; Takemura Y
Metabolism; 1998 Mar; 47(3):362-5. PubMed ID: 9500578
[TBL] [Abstract][Full Text] [Related]
18. The effect of microalbuminuria on glycaemic control, serum lipids and haemostasis parameters in non-insulin-dependent diabetes mellitus.
Donders SH; Lustermans FA; van Wersch JW
Ann Clin Biochem; 1993 Sep; 30 ( Pt 5)():439-44. PubMed ID: 8250495
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus.
Shimano H; Takahashi K; Kawakami M; Gotoda T; Harada K; Shimada M; Yazaki Y; Yamada N
Clin Chim Acta; 1994 Mar; 225(2):89-96. PubMed ID: 8088010
[TBL] [Abstract][Full Text] [Related]
20. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
